Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000147086 | SCV000170910 | benign | not specified | 2012-12-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000147086 | SCV000194442 | uncertain significance | not specified | 2014-10-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000147086 | SCV000231001 | benign | not specified | 2014-11-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000233996 | SCV000286297 | benign | Developmental and epileptic encephalopathy, 9 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000416088 | SCV000493317 | uncertain significance | not provided | 2017-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312582 | SCV000845969 | likely benign | Inborn genetic diseases | 2016-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003935201 | SCV004752672 | likely benign | PCDH19-related condition | 2019-04-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000233996 | SCV000734796 | likely benign | Developmental and epileptic encephalopathy, 9 | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000416088 | SCV001966543 | likely benign | not provided | no assertion criteria provided | clinical testing |